Biotek-snakken — Oktober 2024

[exitnu]

FDA Meetings, Conferences and Workshops

https://www.fda.gov/news-events/live-biotherapeutic-products-prevent-necrotizing-enterocolitis-very-low-birth-weight-infants

[exitnu]

Ascelia Pharma presenterar Late Breaking Abstract av SPARKLE-data vid American Society of Nephrology Kidney Week Congress 2024

Ascelia Pharma Presents Late-Breaking Abstract on SPARKLE Data at the American Society of Nephrology Kidney Week Congress 2024 – ASCELIA

Ascelia Pharma AB (publ) (ticker: ACE), a biotech focused on improving the life of people living with rare cancer conditions, today announce ...

(www.ascelia.com)

.. The presentation will be held on October 24, 2024, from 10:00 AM to 12:00 PM, and will be part of the Late-Breaking Science Posters session. ..

[ProinvestorNEWS]

Selskabspræsentation: Mød Cessatech på tirsdag.

Webinarinfo

Dato:

29.10.2024

Tid:

16:00

Sted:

Online https://www.nordnet.dk/events/selskabspraesentation-cessatech?utm_source=ACS&utm_medium=email&utm_campaign=DK_webinar_cessatech_241024

[ProinvestorNEWS]

The Ultimate Biotech Stock to Buy With $50 Right Now https://proinvestor.com/investornyt/1233181/the-ultimate-biotech-stock-to-buy-with-50-right-now

[Fandel]

Godmorgen...

[LP90]

Godmorgen

[ProinvestorNEWS]

AlzeCure presents new positive data for the TrkA-NAM pain project against osteoarthritis https://storage.mfn.se/67262b49-af19-46f1-892a-84f1a7b0d86e/alzecure-presents-new-positive-data-for-the-trka-nam-pain-project-against-osteoarthritis.pdf

[Sukkeralf]

Flot glue degrader aftale af Monte Rosa Therapeutics med Novartis på et ret ukendt target.

[Sukkeralf]

https://ir.monterosatx.com/news-releases/news-release-details/monte-rosa-therapeutics-announces-global-license-agreement

[Sukkeralf]

Altid svært at sammenligne aftaler, når man ikke kender ret mange detaljer - 2,1 milliard dollars i milestonebetalinger nok det mest prangende, men sikkert på bekostning andre steder. Men men men degraders fylder stille og roligt mere og mere i landskabet.

[ProinvestorNEWS]

Bioporto indgår aftale med Beckman Coulter om distribution https://proinvestor.com/investornyt/1233817/bioporto-indgar-aftale-med-beckman-coulter-om-distribution

[Fandel]

De begynder at levere!

[Fandel]

Godmorgen...

[ProinvestorNEWS]

AbbVie adds anti-amyloid asset to its CNS repertoire in $1.4B-buyout of Aliada https://firstwordpharma.com/story/5907150

[LP90]

Godmorgen

[Fandel]

Første patient indrulleret - BioPorto har påbegyndt indrullering til det amerikanske studie vedrørende ProNephro AKI (NGAL) til voksen brug ved Massachusetts General Hospital

[Fandel]

Godmorgen...

[ProinvestorNEWS]

Biogen And Neomorph Collaborate To Develop Molecular Glue Degraders For Alzheimer's And More https://proinvestor.com/investornyt/1234743/biogen-and-neomorph-collaborate-to-develop-molecular-glue-degraders-for-alzheimers-and-more

[LP90]

Godmorgen

[Sukkeralf]

Zymeworks står overfor sin første mulige godkendelse med PDUFA date den 29 november for zanidatamab. De har 6 investorpræsentationer i den kommende tid, så de retter i den grad fokus på sig selv!